“Millions of patients with severe and rare disorders still suffer without meaningful treatment options. We are proceeding with an unswerving urgency to identify and advance life-transforming therapeutic candidates for patients in need.”
— Martin Mackay, PhD, Co-Founder
Rallybio Newsroom
January 21, 2021 | Press Releases
Steven Tuch Joins Rallybio to Lead Corporate Development
November 24, 2020 | Press Releases
Rallybio to Present at the 3rd Annual Evercore ISI HealthCONx Conference
November 10, 2020 | Press Releases
Rallybio Announces First-in-Human Dosing in RLYB211 Phase 1/2 Study
November 5, 2020 | Press Releases
Rallybio to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
November 2, 2020 | Press Releases
Rallybio Appoints Paula Soteropoulos to Board of Directors
September 11, 2020 | Press Releases
Rallybio to Present at the Morgan Stanley 18th Annual Global Healthcare Conference